Iambic Therapeutics, Inc. Common Stock

IAM

市值 US$11.3億

23.81 USD

+4.90

25.91%

收盤時已更新 10月16日下午4:00 EDT

盤前交易

盤後交易

24.00

+0.19

0.8%

1天

25.91%

5天

47.43%

1個月

25.91%

3個月

25.91%

6個月

25.91%

今年迄今

25.91%

1年

25.91%

5年

25.91%

10年

25.91%

關於： Iambic Therapeutics Inc is a technology and clinical-stage life sciences company developing novel medicines using its proprietary molecular superintelligence platform.

醫療保健藥品製造商－一般

新聞

正面

中性

負面

市場情緒 3個月

正面 0%

中性 100%

負面 0%

中性

Seeking Alpha

昨天

U.S. IPO Weekly Recap: Biotechs City Therapeutics And Iambic Headline The Week's Pricings

Three IPOs and two SPACs priced this week, and two SPACs submitted filings. No IPOs are currently scheduled for the week ahead as the year's next mega IPO potentially comes into view. Street research is expected to for one company in the week ahead, and four lock-up periods will be expiring.

查看新聞排名

價格圖表採用Lightweight Charts™實作

Iambic Therapeutics, Inc. Common Stock IAM 市值 US$11.3億

新聞

Iambic Therapeutics, Inc. Common Stock

IAM

市值 US$11.3億